Freenome Lung Cancer Blood Test Receives FDA Breakthrough Device Status

Reports

2

Domains carrying it

2

First reported

13 August 2026

Latest report

14 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 13 August 2026Freenome Lung Cancer Blood Test Receives FDA Breakthrough Device Statuspatientcareonline.com
2. 14 August 2026Blood-Based Lung Cancer Screening Tool Earns FDA Breakthrough Device Statuscancernetwork.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA Approves Freenome's SimpleScreen™ CRC Blood-Based Screening Test4 reports · 4 domains · 28 July 2026
• FDA Approves Blood-Based Test for Colorectal Cancer Screening2 reports · 2 domains · 5 August 2026
• J&J's Monarch robot wins FDA nod for AI features4 reports · 4 domains · 18 August 2026
• Pancreatic cancer drug approved by FDA is "exceptional moment," Boston researcher says3 reports · 3 domains · 3 September 2026
• US FDA approves Takeda, Protagonist's drug for rare blood cancer3 reports · 3 domains · 1 September 2026
• FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder14 reports · 12 domains · 1 September 2026

◆ Share

◆ Evidence

2 reports · 2 domains

• Blood-Based Lung Cancer Screening Tool Earns FDA Breakthrough Device Statuscancernetwork.com · 14 August 2026
• Freenome Lung Cancer Blood Test Receives FDA Breakthrough Device Statuspatientcareonline.com · 13 August 2026